BlackRock Institutional Trust’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$19.5M Buy
1,224,332
+119,021
+11% +$1.9M ﹤0.01% 1983
2016
Q3
$18.4M Sell
1,105,311
-3,543
-0.3% -$59K ﹤0.01% 1949
2016
Q2
$12.4M Buy
1,108,854
+15,575
+1% +$174K ﹤0.01% 2157
2016
Q1
$9.14M Buy
1,093,279
+15,237
+1% +$127K ﹤0.01% 2311
2015
Q4
$10M Buy
1,078,042
+21,677
+2% +$202K ﹤0.01% 2320
2015
Q3
$11.9M Sell
1,056,365
-69,891
-6% -$788K ﹤0.01% 2164
2015
Q2
$14.3M Buy
1,126,256
+15,107
+1% +$192K ﹤0.01% 2154
2015
Q1
$10.3M Sell
1,111,149
-26,421
-2% -$246K ﹤0.01% 2376
2014
Q4
$16.3M Buy
1,137,570
+82,929
+8% +$1.19M ﹤0.01% 2035
2014
Q3
$10.9M Sell
1,054,641
-12,957
-1% -$134K ﹤0.01% 2268
2014
Q2
$17.3M Sell
1,067,598
-12,272
-1% -$199K ﹤0.01% 2062
2014
Q1
$17.5M Buy
1,079,870
+34,884
+3% +$567K ﹤0.01% 2052
2013
Q4
$13M Buy
1,044,986
+41,444
+4% +$514K ﹤0.01% 2240
2013
Q3
$11M Buy
1,003,542
+91,168
+10% +$998K ﹤0.01% 2300
2013
Q2
$7.37M Buy
+912,374
New +$7.37M ﹤0.01% 2492